APA Citatie

de Silva, M., Itchins, M., & Pavlakis, N. (2020). Breakthrough 5-year survival with pembrolizumab in Keynote-001 study: Horizon shifting in advanced non-small cell lung cancer with immune check point inhibition. Ann Transl Med.

Chicago Style citaat

de Silva, Madhawa, Malinda Itchins, en Nick Pavlakis. "Breakthrough 5-year Survival With Pembrolizumab in Keynote-001 Study: Horizon Shifting in Advanced Non-small Cell Lung Cancer With Immune Check Point Inhibition." Ann Transl Med 2020.

MLA citatie

de Silva, Madhawa, Malinda Itchins, en Nick Pavlakis. "Breakthrough 5-year Survival With Pembrolizumab in Keynote-001 Study: Horizon Shifting in Advanced Non-small Cell Lung Cancer With Immune Check Point Inhibition." Ann Transl Med 2020.